AU9633098A - Benzoxazine derivatives, preparation and application in therapy - Google Patents

Benzoxazine derivatives, preparation and application in therapy

Info

Publication number
AU9633098A
AU9633098A AU96330/98A AU9633098A AU9633098A AU 9633098 A AU9633098 A AU 9633098A AU 96330/98 A AU96330/98 A AU 96330/98A AU 9633098 A AU9633098 A AU 9633098A AU 9633098 A AU9633098 A AU 9633098A
Authority
AU
Australia
Prior art keywords
therapy
preparation
application
benzoxazine derivatives
benzoxazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU96330/98A
Inventor
Michel Aletru
Philippe R Bovy
Luc Even
Claudie Gautier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Publication of AU9633098A publication Critical patent/AU9633098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU96330/98A 1997-10-21 1998-10-16 Benzoxazine derivatives, preparation and application in therapy Abandoned AU9633098A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9713149 1997-10-21
FR9713149A FR2769915B1 (en) 1997-10-21 1997-10-21 TRICYCLIC INDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
PCT/FR1998/002221 WO1999020633A1 (en) 1997-10-21 1998-10-16 Benzoxazine derivatives, preparation and application in therapy

Publications (1)

Publication Number Publication Date
AU9633098A true AU9633098A (en) 1999-05-10

Family

ID=9512452

Family Applications (1)

Application Number Title Priority Date Filing Date
AU96330/98A Abandoned AU9633098A (en) 1997-10-21 1998-10-16 Benzoxazine derivatives, preparation and application in therapy

Country Status (9)

Country Link
EP (1) EP1025109A1 (en)
JP (1) JP2001520231A (en)
AR (1) AR017366A1 (en)
AU (1) AU9633098A (en)
CO (1) CO4990933A1 (en)
FR (1) FR2769915B1 (en)
TW (1) TW407160B (en)
WO (1) WO1999020633A1 (en)
ZA (1) ZA989556B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6558708B1 (en) * 1995-05-17 2003-05-06 Cedars-Sinai Medical Center Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
FR2792318B1 (en) * 1999-04-16 2001-06-15 Synthelabo INDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
AR036040A1 (en) 2001-06-12 2004-08-04 Upjohn Co MULTICICLIC HETEROARYL COMPOUNDS REPLACED WITH QUINUCLIDINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PL369895A1 (en) 2001-10-02 2005-05-02 Pharmacia & Upjohn Company Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
CA2466344A1 (en) 2001-11-09 2003-05-22 Pharmacia & Upjohn Company Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands
US6858613B2 (en) 2002-02-19 2005-02-22 Pfizer Inc. Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease
JP2005523287A (en) 2002-02-19 2005-08-04 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー Azabicyclo compounds for disease treatment
TW200533348A (en) 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US7728006B2 (en) 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
DE602005016446D1 (en) 2004-11-05 2009-10-15 Theravance Inc 5-HT4 receptor agonist compounds
ATE431824T1 (en) 2004-11-05 2009-06-15 Theravance Inc QUINOLINONE-CARBOXAMIDE COMPOUNDS
ES2347265T3 (en) 2004-12-22 2010-10-27 Theravance, Inc. INDAZOL-CARBOXAMIDA COMPOUNDS.
DE602005019094D1 (en) * 2004-12-22 2010-03-11 Memory Pharmaceutical Corp NICOTINE ALPHA-7 RECEPTOR LIGANDS AGAINST DISEASES OF THE CNS
KR20070107807A (en) 2005-03-02 2007-11-07 세라밴스 인코포레이티드 Quinolinone compounds as 5-ht4 receptor agonists
JP4375749B2 (en) 2005-11-22 2009-12-02 本田技研工業株式会社 Resin garnish structure for vehicles
WO2007120599A2 (en) * 2006-04-12 2007-10-25 Wyeth Dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950759A (en) * 1988-07-07 1990-08-21 Duphar International Research B.V. Substituted 1,7-annelated 1H-indazoles
FR2753196B1 (en) * 1996-09-12 1998-10-23 Synthelabo TRICYCLIC INDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Also Published As

Publication number Publication date
CO4990933A1 (en) 2000-12-26
EP1025109A1 (en) 2000-08-09
FR2769915A1 (en) 1999-04-23
AR017366A1 (en) 2001-09-05
JP2001520231A (en) 2001-10-30
TW407160B (en) 2000-10-01
ZA989556B (en) 1999-04-20
WO1999020633A1 (en) 1999-04-29
FR2769915B1 (en) 2000-10-13

Similar Documents

Publication Publication Date Title
AU3957600A (en) Piperidyl-imidazole derivatives, their preparations and therapeutic uses
AU5970298A (en) Dithiolan derivatives, their preparation and their therapeutic effect
AU9633098A (en) Benzoxazine derivatives, preparation and application in therapy
AU4679297A (en) 3-hydroxypyridine-2-carboxamidoesters, their preparation and their use as pharmaceuticals
EP1072266B8 (en) Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
AU2922600A (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
AU1280100A (en) Novel 2-pyridone derivatives, preparation method and therapeutic use
AU5161399A (en) N-benzocycloalkyl-amide derivatives and their use as medicaments
AU4071295A (en) 3-phenylisoquinol-1(2H)-one derivatives, their preparation and their therapeutic application
AU5652096A (en) Azacycloalcane derivatives, their preparation and their applications in therapy
AU3301700A (en) (n)-sulfonyl-dipeptide derivatives, production and use thereof in therapy
AU7095296A (en) Phosphorylamides, their preparation and use
HUP9904206A3 (en) 1,4-diazabicyclo[2.2.2.]oct-2-ylmethyl derivatives,their preparation and therapeutic application
HK1028027A1 (en) 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b)-indole-1-acetamide derivatives, their preparation and their application in therapy
AU1638095A (en) Boronic peptide derivatives, preparation and therapeutic application thereof
ZA989664B (en) 3-substituted tetrahydropyrimidinone derivatives, their preparation and use.
AU1243399A (en) Imidazole derivatives, preparation and therapeutic application thereof
AU6128896A (en) Isoindole derivatives, their preparation and their application in therapy
AU2030197A (en) 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof
AU4463897A (en) N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics
IL135520A0 (en) 8-azabicyclo [3.2.1.] octane-3-methanamine derivatives, their preparation and their therapeutic application
AU3853097A (en) Benzimidazole derivatives, preparation thereof, and therapeutical uses thereof
AU6705296A (en) Benzenesulphonamide derivatives, their preparation and their applications in therapy
IL133536A0 (en) 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy
AU3023497A (en) Phthalazine derivatives, their preparation and their use as drugs

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase